- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03674684
ROTEM Assessment of Modern Crystalloid, Hydroxyethyl Starch and Gelatin Effect on Coagulation
September 17, 2018 updated by: Durila Miroslav MUDr. Ph.D., University Hospital, Motol
Rotational Thromboelastometry (ROTEM) Assessment of Modern Crystalloid, Hydroxyethyl Starch and Gelatin Effect on Coagulation in Vivo
Modern crystalloid and colloid solutions are balanced solutions which are increasingly used in perioperative period.
However, studies investigating their negative effect on whole blood coagulation are missing.
The aim of our study was to assess the effect of modern balanced crystalloid and colloid solutions on whole blood coagulation in vivo using rotational thromboelastometry.
Study Overview
Detailed Description
Blood samples were obtained from 30 patients during knee arthroscopy before and after administration of 500 ml of modern balanced crystalloid, hydroxyethyl starch (HES) or gelatin.
Rotational thromboelastometry (EXTEM, INTEM and FIBTEM tests) were performed to assess negative effect of fluid solutions on whole blood coagulation.
Study Type
Observational
Enrollment (Actual)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Praha, Hlavní Město
-
Prague, Praha, Hlavní Město, Czechia, 15006
- Miroslav Durila
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
healthy patients undergoing knee arthroscopy
Description
Inclusion Criteria:
- healthy patients undergoing knee arthroscopy
Exclusion Criteria:
- receiving antiplatelet drugs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
hydroxyethyl starch
Patients who received hydroxyethyl starch
|
After induction to anaesthesia patients received either hydroxyethyl starch or gelatin or crystalloids
|
gelatin
Patients who received gelatin
|
After induction to anaesthesia patients received either hydroxyethyl starch or gelatin or crystalloids
|
crystalloids
Patients who received crystalloids
|
After induction to anaesthesia patients received either hydroxyethyl starch or gelatin or crystalloids
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
thromboelastometry assessment of coagulation
Time Frame: 3 months
|
ROTEM tests- clotting time in seconds, Maximal clot firmness in mm, alpha angle of in degree of following tests EXTEM, INTEM, FIBTEM
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Miroslav Durila, Second Medical Faculty, Charles University and University Hospital Motol
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 14, 2017
Primary Completion (Actual)
July 14, 2018
Study Completion (Actual)
August 14, 2018
Study Registration Dates
First Submitted
September 14, 2018
First Submitted That Met QC Criteria
September 14, 2018
First Posted (Actual)
September 17, 2018
Study Record Updates
Last Update Posted (Actual)
September 19, 2018
Last Update Submitted That Met QC Criteria
September 17, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14092018 Motol Hospital
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coagulopathy
-
University of ZurichCompleted
-
Emory UniversityWithdrawnTrauma-induced CoagulopathyUnited States
-
Mahidol UniversityCompleted
-
Goethe UniversityUnknownCoagulopathy During Cardiac SurgeryGermany, Austria
-
CSL BehringCompletedReversal of CoagulopathyUnited States, Belarus, Bulgaria, Lebanon, Romania, Russian Federation
-
Johns Hopkins UniversityTerminatedCirrhosis, Coagulopathy
-
The Hospital for Sick ChildrenSynapse B.V. Research Institute, University of MaastrichtUnknownPlatelet Function Tests | Thrombin Generation Tests | Perioperative CoagulopathyCanada
-
Monash UniversityNational Health and Medical Research Council, Australia; Health Research Council...CompletedPre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study) (PATCH)Wounds and Injuries | Acute CoagulopathyAustralia, New Zealand
-
Zdravotnicka Zachranna Sluzba Kralovehradeckeho...University Hospital Hradec KraloveUnknownWounds and Injuries | Trauma | Acute CoagulopathyCzechia
-
Petra Hartmann MD Ph.D.Not yet recruiting
Clinical Trials on hydroxyethyl starch
-
University of Sao PauloCompletedHip Replacement ArthroplastyBrazil
-
Fresenius KabiCompletedPostoperative ComplicationsChina
-
General Hospital of Ningxia Medical UniversityCompleted
-
Fresenius Kabi JapanCompletedPlasma Volume Substitution (Hypovolemia) Including Massive HemorrhageJapan
-
Regional Hospital HolstebroTerminated
-
Yuanyuan ZhangTianjin First Central Hospital; Tianjin Union Medical CenterCompletedTotal Fluid Volume IncreasedChina
-
Regional Hospital HolstebroCompleted
-
Lawson Health Research InstituteWestern University, CanadaCompletedCardiac Surgical Procedures
-
Asan Medical CenterCompletedPancreaticoduodenectomyKorea, Republic of